Roche’s Actemra May Curb Deaths in Critical Covid Patients
A nurse wearing a powered air-purifying respirator checks on a patients vital signs inside the Covid-19 ICU at PeaceHealth Southwest Medical Center in Vancouver, Washington, U.S. (Photographer: Nathan Howard/Bloomberg)

Roche’s Actemra May Curb Deaths in Critical Covid Patients

(Bloomberg) -- Roche Holding AG’s Actemra may help critically ill patients survive Covid-19, according to researchers who used a novel approach to show those who quickly got the anti-inflammatory m...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.